Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Thursday, July 2

POSER S S INS Ta A41101 -411

Track A: Basic Science
41101 Interactions of secretory IgA with HIV-1 gp120: Potential pitfalls
ofanti-HIV ELISA using saliva
Susan Jackson*; SJ. Prince; R. Kulhavy;J. Mestecky, USA
41102 HIV-screening with the Elecsys automated analyser:
Combined testing for anti-HIV and HIVAg within 18 minutes
Friddric Donie*; B. Upmeier; E. Hoess; E. Faatz, Germany
41103 Detection of memory T cells in HIV+ individuals: Cytokine producing
lymphocyte precursors (CPLp)
Kendall A. Smith*; G. Chiocchia; F. Pilaro; E.L. Jacobson; R. Emert, USA
41104 Universal peptide for detection of HIV-1 group M and group 0
infections in rapid immunoassay
Afzal Chowdhury*; J.M. Lovchik; M.A. Childs; D. Bernstein, USA
41105 Evaluation of a locally produced particle agglutination assay for
detection of antibodies to HIV-1
Wilfred James Njoroge*; C. W. Mutura; W.A. Mwangi; N. Sakagami;
K. Kakimoto; P.M. Tukei; T. Kurimura, Japan
41106 Murex HIV-1.2.0 is a highly sensitive and specific assay for antibodies
to HIV-1/M, HIV-1/0 and HIV-2
Richard Bristow*, T. Carter; K. Francis; J. Lovell; B. Rodgers; D. Trotter;
P. Weston, UK
41107 Detection of HIV-1 Subtypes by a new rapid immunochromatographic
test
Hiroyasu Arai*; S. Devare; T. Kosaka; K. Takeda, Japan
41108 Validation study of HIV testing in urine samples
David Mabey*; John Changalucha; B. West; D. Ross; R. Balira; J. Todd;
T Boerma; D. Mabey, UK
41109 Predictors of HIV-infection among professional blood donors with
Western Blot Indeterminate results (WBI)
Usha K. Baveja*; D. Chattopadhya; R.K. Aggarwal; V. Doda; S. Kumari;
J. Sokhey, India
41110 HIV antibody actity measurement how to distinguish primoinfected
from old infected patients using one ELISA test adapted to AXSYM
Automate
Christopher Paxan; A. Lemeur; B. Evreux; S. Kouyoumdjian;
J-M. Chennebault; F. Lunel
41111 Identification of a new virus-associated epitope inducing antibody
responsible for the non-progression to AIDS
Pascale Galea*; CR. Steinhart; P. Willem; N. Profizi; C. Lecontel;
J.C Chermann, France
41112 In vitro"HIV-1 antibody induction.Testing of the "Shiloov Tube
Carmen Soler Claudin*; C. Gomez Palomino; T. Jehuda-Cohen, Mexico
41113 A new generation of HIV-diagnostic assay: Results of the evaluation
ofthe Enzymun-Tests HIV combi
Eluke Faatz*; F. Donie; W. Melhior; B. Upmeier; C. Seidel, Germany
41114 Performance ofcalypte HIV-1 urine EIA in three us populations
Dean Schoer*; V. Mitteco; T. Gottfried; M. Kanar, USA
41115 Performance ofan HIV-1, HIV-2and HIV-1 group0 immunoassay
on the Abbott ARCHITECTT 2000 analyzer

William Black*- S. Stewart; A. Hoffman;J. Prostko; L. Xu, USA

41116 A new approach to flow cytometry-based CD4 T-cell enumeration
for absolute and percentage values
Michele Bergeron*; F.F. Mandy; T. Ding; S. Phaneuf, Canada
41117 Sensivity evaluation ofVironostika Uni-Form II plus 0 with samples
from Thailand
Thippawan Chuenchitra, Thailand
41118 HIV-screening with the Elecsys, automated analyser:Testing for HIVAg
within 18 minutes with a sensitivity of 3 pg/ml
Urban Schmitt*; D. Schlieper; B. Upmeier; W. Melchior; E. Faatz,
Germany
41119 Anti HIV1/2 mass testing, what should be done?
Alexandre M. Oliveira*; C.C. Hofling; M.C. Ramos; S.A.A. Chaves, Brazil
41120 Rapid, 3rd generation one-step immunoassay for HIV antibodies,
useful in developing countries
Jesus Benitez; O. Ganzo; J. Rivero; J. Gavilondo, Cuba
41121 Seroprevalence of HIV-infection among street children in Maiduguri
Edemenang D. Okpudo-ltata*; T.O. Harry; M. Bulterys; A. Abimiku,
Nigeria
41122 Sensitivity of HIV-1 group M Western blot for the confirmation of
HIV-1 group 0 infections, according to different interpretation criteria
Charlotte Ngansop*; Seraphin Kuate; L. Zekeng; M. Kengne; L. Kaptue,
Cameroon
41123 Prevalence and control of STDs/HIV among commercial sex workers
(CSW)
Jyotsna Shrestha*; V.L. Gurubacharya, Nepal
41124 Modifications in the DTH reaction in HIV-infected individuals
Kamen Plochev, Bulgaria
41125 Evaluation of a fast method (HIVSAV,) for serologic diagnosis of HIV-1 e 2
Draurio Barreira*; G. Silva; H.M.V. Oliveira; Y. Bravin, Brazil
41126 Immunological monitoring in HIV-infection
YuriMitin*; E.I. Zmushko; A.N. Malkov, Russia
41127 Field evaluation of the HIV-1 Amplicor Monitor and NucliSens
quantitative HIV-1 RNA PCR assay in persons infected with
HIV-1 subtype A in Abidjan, COte d'lvoire
John Nkenga Song*; M. Kalou; C. Bile; M. Y. Borget; M. Morokro;
E.R. Ekpini; P. Ghys; A.E. Greenberg; S.Z. Wiktor, COte d'lvoire
41128 Comparative evaluation of amplicor HIV-1 monitor with added primer
set with quantiplex v2.0 HIV RNA assay and the nuclisensfor quantitation
of HIV-1 RNA in a Thai study population,primarily infected with subtype E
Sasiwimol Ubolyam*; K. Ruxrungtham; G.. Weverling;
C. Ungsidhapand; J. Lange; D. Cooper; P. Phanuphak, Thailand
41129 High throughput assay for sensitive detection of HIV-1 RNA of diverse
origins, including type 0 strains
Cristina Giachetti*; D. Kolk; J. Dockter; J.P. Knowlton; R. Wang; S.
Hotaling; S. McDonough, USA
41130 Sensitivity, linear range and performance of HIV-1 subtypes of the
COBASAMPLICOR HIV-1 monitor test
Cynthia Pletcher*; D. De Bonville; J. Wang; K. Lavallee; A. Chutoransky;
K. Arch; A. Wang, USA

186

12th World AIDS Conference Geneva